Intravenous administration of the conditionally replicative adenovirus Ad5-Delta24RGD induces regression of osteosarcoma lung metastases

H.C. Graat; V.W. van Beusechem; F.H. Schagen; M.A. Witlox; E.S. Kleinerman; M.N. Helder; W.R. Gerritsen; G.J.L. Kaspers; P.I. Wuisman

doi:10.1186/1476-4598-7-9

Intravenous administration of the conditionally replicative adenovirus Ad5-Delta24RGD induces regression of osteosarcoma lung metastases

H.C. Graat
, V.W. van Beusechem
, F.H. Schagen
, M.A. Witlox
, E.S. Kleinerman
, M.N. Helder
, W.R. Gerritsen
, G.J.L. Kaspers
, P.I. Wuisman

Research output: Contribution to journal › Article › Academic › peer-review

21 Downloads (Pure)

Original language	Undefined/Unknown
Pages (from-to)	9
Journal	Molecular cancer
Volume	7
DOIs	https://doi.org/10.1186/1476-4598-7-9
Publication status	Published - 2008

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Access to Document

10.1186/1476-4598-7-9

289128Final published version, 356 KB

Cite this

@article{ab03da20341d49faa5f5e57be3b2a629,

title = "Intravenous administration of the conditionally replicative adenovirus Ad5-Delta24RGD induces regression of osteosarcoma lung metastases",

author = "H.C. Graat and \{van Beusechem\}, V.W. and F.H. Schagen and M.A. Witlox and E.S. Kleinerman and M.N. Helder and W.R. Gerritsen and G.J.L. Kaspers and P.I. Wuisman",

year = "2008",

doi = "10.1186/1476-4598-7-9",

language = "Undefined/Unknown",

volume = "7",

pages = "9",

journal = "Molecular cancer",

issn = "1476-4598",

publisher = "BioMed Central Ltd.",

}

TY - JOUR

T1 - Intravenous administration of the conditionally replicative adenovirus Ad5-Delta24RGD induces regression of osteosarcoma lung metastases

AU - Graat, H.C.

AU - van Beusechem, V.W.

AU - Schagen, F.H.

AU - Witlox, M.A.

AU - Kleinerman, E.S.

AU - Helder, M.N.

AU - Gerritsen, W.R.

AU - Kaspers, G.J.L.

AU - Wuisman, P.I.

PY - 2008

Y1 - 2008

U2 - 10.1186/1476-4598-7-9

DO - 10.1186/1476-4598-7-9

M3 - Article

C2 - 18215325

SN - 1476-4598

VL - 7

SP - 9

JO - Molecular cancer

JF - Molecular cancer

ER -